| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |